Immunome, Inc.IMNMNASDAQ
Loading
Debt to Equity Over TimeElevated
Percentile Rank29
3Y CAGR-29.7%
5Y CAGR-16.3%
Year-over-Year Change
Debt-to-equity ratio
3Y CAGR
-29.7%/yr
Annual compound
5Y CAGR
-16.3%/yr
Recent deceleration
Percentile
P29
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive declineElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.01 | -77.2% |
| 2024 | 0.03 | +93.8% |
| 2023 | 0.01 | -21.2% |
| 2022 | 0.02 | +165.6% |
| 2021 | 0.01 | -55.6% |
| 2020 | 0.01 | +193.7% |
| 2019 | -0.02 | +66.1% |
| 2018 | -0.05 | - |